Lysostaphin in experimental renal infections.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000906:Antibodies / Q000627:therapeutic use*; D007612:Kanamycin / Q000494:pharmacology; D007674:Kidney Diseases / Q000188:drug therapy*; D007677:Kidney Function Tests; D008034:Lincomycin / Q000494:pharmacology; D008248:Lysostaphin / Q000627:therapeutic use; D051379:Mice; D010406:Penicillins / Q000494:pharmacology; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000401:mortality; D013210:Staphylococcus / Q000187:drug effects; D014640:Vancomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D000906:Antibodies; D010406:Penicillins; D007612:Kanamycin; D014640:Vancomycin; D008034:Lincomycin; D008248:Lysostaphin